Cargando…

Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor

The diagnosis of primary angiosarcoma of ovary is still a challenge as it has no specific clinical symptoms and is easily confused with other malignant neoplasms in morphology. Here, we described a case of primary ovarian angiosarcoma and reviewed the literature. A 47-year-old female showed a left o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Hong, Lin, Min, Li, Ruotong, Qin, Shuming, Hou, Gang, Chen, Hongzhi, Li, Xiaomei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844967/
https://www.ncbi.nlm.nih.gov/pubmed/33509230
http://dx.doi.org/10.1186/s13048-021-00771-7
_version_ 1783644462404075520
author Ye, Hong
Lin, Min
Li, Ruotong
Qin, Shuming
Hou, Gang
Chen, Hongzhi
Li, Xiaomei
author_facet Ye, Hong
Lin, Min
Li, Ruotong
Qin, Shuming
Hou, Gang
Chen, Hongzhi
Li, Xiaomei
author_sort Ye, Hong
collection PubMed
description The diagnosis of primary angiosarcoma of ovary is still a challenge as it has no specific clinical symptoms and is easily confused with other malignant neoplasms in morphology. Here, we described a case of primary ovarian angiosarcoma and reviewed the literature. A 47-year-old female showed a left ovary mass. Grossly, the cut surface of the tumor was solid and gray-white with intermediate texture. Some areas were spongy and atropurpureus with a soft texture. Microscopically, the tumor cells were arranged into a variety of different structures with visible hemorrhage. Immunochemically, the tumor cells were positive for CD31, ERG, Fli1, D2–40 and vimentin in a strong and diffused manner. CD34 stain showed focal positivity. Epithelial markers (e.g. CK, CK7, CK8/18 and PAX8) were all negative. Negative immunostaining for SMA, S-100, P53 and calretinin also were detected. The proliferative index (Ki-67) was approximately 40%. After surgery, the patient was treated with radiotherapy, targeted therapy and immunotherapy. In the 9-month follow-up, the patient was survival without evidence of disease. The diagnosis of ovarian angiosarcoma required the careful observation of morphology and the reasonable application of immunohistochemistry. Targeted therapy and immunotherapy are the potential directions for the treatment of angiosarcoma.
format Online
Article
Text
id pubmed-7844967
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78449672021-02-01 Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor Ye, Hong Lin, Min Li, Ruotong Qin, Shuming Hou, Gang Chen, Hongzhi Li, Xiaomei J Ovarian Res Case Report The diagnosis of primary angiosarcoma of ovary is still a challenge as it has no specific clinical symptoms and is easily confused with other malignant neoplasms in morphology. Here, we described a case of primary ovarian angiosarcoma and reviewed the literature. A 47-year-old female showed a left ovary mass. Grossly, the cut surface of the tumor was solid and gray-white with intermediate texture. Some areas were spongy and atropurpureus with a soft texture. Microscopically, the tumor cells were arranged into a variety of different structures with visible hemorrhage. Immunochemically, the tumor cells were positive for CD31, ERG, Fli1, D2–40 and vimentin in a strong and diffused manner. CD34 stain showed focal positivity. Epithelial markers (e.g. CK, CK7, CK8/18 and PAX8) were all negative. Negative immunostaining for SMA, S-100, P53 and calretinin also were detected. The proliferative index (Ki-67) was approximately 40%. After surgery, the patient was treated with radiotherapy, targeted therapy and immunotherapy. In the 9-month follow-up, the patient was survival without evidence of disease. The diagnosis of ovarian angiosarcoma required the careful observation of morphology and the reasonable application of immunohistochemistry. Targeted therapy and immunotherapy are the potential directions for the treatment of angiosarcoma. BioMed Central 2021-01-28 /pmc/articles/PMC7844967/ /pubmed/33509230 http://dx.doi.org/10.1186/s13048-021-00771-7 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Ye, Hong
Lin, Min
Li, Ruotong
Qin, Shuming
Hou, Gang
Chen, Hongzhi
Li, Xiaomei
Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor
title Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor
title_full Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor
title_fullStr Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor
title_full_unstemmed Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor
title_short Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor
title_sort primary ovarian angiosarcoma: a rare and recognizable ovarian tumor
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844967/
https://www.ncbi.nlm.nih.gov/pubmed/33509230
http://dx.doi.org/10.1186/s13048-021-00771-7
work_keys_str_mv AT yehong primaryovarianangiosarcomaarareandrecognizableovariantumor
AT linmin primaryovarianangiosarcomaarareandrecognizableovariantumor
AT liruotong primaryovarianangiosarcomaarareandrecognizableovariantumor
AT qinshuming primaryovarianangiosarcomaarareandrecognizableovariantumor
AT hougang primaryovarianangiosarcomaarareandrecognizableovariantumor
AT chenhongzhi primaryovarianangiosarcomaarareandrecognizableovariantumor
AT lixiaomei primaryovarianangiosarcomaarareandrecognizableovariantumor